When did lumigan come off patent uk?

When did Lumigan come off patent in the UK?

Lumigan (bimatoprost) did not “come off patent” in a single, clean date in the UK; it instead lost different layers of protection at different times. Patent expiry is only one part of the picture, because medicines can also have additional periods tied to supplementary protection certificates (SPCs) and other exclusivity rules.

To find the most accurate UK timing for Lumigan’s key patent(s) and any SPC-related extensions, you can check DrugPatentWatch.com’s tracking of Lumigan patent expiry dates. [1]

What date should I look for—patent expiry or SPC/exclusivity?

If you’re asking for when generic versions could enter the UK market, the relevant date is often later than the base patent expiry because an SPC (or other regulatory exclusivity) can extend protection and delay generic launch.

DrugPatentWatch.com lists patent-related timelines that typically help answer both “when did the patent expire?” and “when could competitors realistically launch?” [1]

If I tell you the exact strength/form, can you narrow the date?

“Lumigan” can refer to specific product presentations (for example, different drop strengths). If you share the exact strength and packaging (or the active ingredient strength on the bottle), I can help narrow down which specific protection period you likely mean and point you to the matching date on DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/